Form 4: CoreWeave CDO Sells Shares via 10b5-1 Plan

CoreWeave's Chief Development Officer, Brannin McBee, executed pre-planned sales of Class A Common Stock totaling 8,825 shares on January 5, 2026, through trusts and a GRAT.

Summary

• Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported transactions involving Class A and Class B Common Stock.
• On January 5, 2026, 8,335 shares of Class B Common Stock were converted into Class A Common Stock.
• Subsequently, 8,335 shares of Class A Common Stock were sold from the Canis Minor 2025 GRAT at weighted average prices ranging from $77.4703 to $84.0431.
• An additional 490 shares of Class A Common Stock were sold from the Canis Major SM Trust at weighted average prices ranging from $77.5246 to $82.84.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
• Following these transactions, the Canis Minor 2025 GRAT holds 949,990 Class B Common Stock, and the Canis Major SM Trust holds 57,000 Class A Common Stock.
• Indirect beneficial ownership also includes 1,800 Class A Common Stock held by the reporting person's child and 2,280,300 Class A Common Stock held by the spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While insider selling can be perceived negatively, the fact that these sales were pre-planned under a Rule 10b5-1 plan mitigates the negative signal, suggesting the sales are for personal financial planning rather than a lack of confidence in the company's future.

Positives

• The sales were executed under a pre-established Rule 10b5-1 trading plan, indicating they were not based on new, non-public information.
• The reporting person and related entities still retain significant indirect beneficial ownership in CoreWeave stock, including 949,990 Class B Common Stock and 57,000 Class A Common Stock through trusts, and 2,280,300 Class A Common Stock through the spouse.

Negatives

• The Chief Development Officer, through related entities, sold a total of 8,825 shares of Class A Common Stock.
• Insider selling, even if pre-planned, can sometimes be perceived as a negative signal regarding management's confidence in the company's near-term stock performance.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions and does not provide information to analyze broader industry trends or competitors.

Related Party Transactions

• Sales of Class A Common Stock were made from the Canis Minor 2025 GRAT, where the reporting person's spouse is the sole beneficiary and trustee.
• Sales of Class A Common Stock were made from the Canis Major SM Trust, an irrevocable trust where the reporting person's minor child is a beneficiary and the reporting person has the power to remove and replace the trustee.

Stakeholder Impact

• Shareholders: The sale of shares by a Chief Development Officer, even if pre-planned, could be interpreted by some shareholders as a slight reduction in insider confidence, potentially leading to minor short-term price fluctuations. However, the pre-planned nature mitigates significant negative impact.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this routine insider transaction filing.

Key Dates

Recommendation

This Form 4 filing details routine insider sales executed under a pre-established 10b5-1 trading plan. Such sales are typically for personal financial management and do not necessarily reflect a change in the insider's long-term outlook for the company. While insider selling can sometimes be a negative signal, the pre-planned nature mitigates this concern. The filing does not provide new fundamental information about CoreWeave's operations, financial performance, or strategic direction that would warrant a change in investment thesis. Therefore, a "hold" recommendation is appropriate, maintaining existing positions while awaiting further operational or financial updates.

Keywords

CoreWeave, CRWV, Form 4, insider trading, stock sale, Class A Common Stock, Class B Common Stock, Brannin McBee, Chief Development Officer, 10b5-1 plan, beneficial ownership